Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

por Walther, Feli M., Allan, Mark J., Roepke, Rainer KA
Publicado 2015

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration

por Kilp, Susanne, Ramirez, Diana, Allan, Mark J, Roepke, Rainer KA
Publicado 2016

Safety of concurrent treatment of cats with fluralaner and emodepsid–praziquantel

por Walther, Feli M., Allan, Mark J., Roepke, Rainer K. A.
Publicado 2016

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel

por Walther, Feli M., Allan, Mark J., Roepke, Rainer K. A.
Publicado 2016

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration

por Walther, Feli M, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Publicado 2014

The effect of food on the pharmacokinetics of oral fluralaner in dogs

por Walther, Feli M, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Publicado 2014

Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration

por Kilp, Susanne, Ramirez, Diana, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Publicado 2014

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel

por Walther, Feli M, Fisara, Petr, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Publicado 2014

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)

por Walther, Feli M, Fisara, Petr, Allan, Mark J, Roepke, Rainer K A, Nuernberger, Martin C
Publicado 2014

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

por Walther, Feli M, Paul, Allan J, Allan, Mark J, Roepke, Rainer KA, Nuernberger, Martin C
Publicado 2014